- The top-tier life sciences company will standardize its
Safety operations on the cloud-powered technology
platform, LifeSphere, which is propelling life sciences GenAI
use cases.
- The company will use LifeSphere MultiVigilance and
Reporting & Analytics Solution to process some 600,000
adverse event cases annually.
BOSTON, June 27,
2024 /PRNewswire/ -- ArisGlobal, a technology company
at the forefront of life sciences and creator of LifeSphere®,
today announced one of the world's largest biotech companies is
live on LifeSphere® MultiVigilance and Reporting & Analytics
Solution.
The company, which processes more than 600,000 adverse event
cases annually and operates across all modern therapy areas and
medical devices, sees the consolidation of core Safety activities
from legacy on-premise systems to LifeSphere as a powerful
means of streamlining the processing of high volumes of incoming
data to deliver world-class patient safety.
As a member of the Life Sciences Generative AI Council,
the biotech innovator is particularly keen to leverage the
capabilities of LifeSphere NavaX, ArisGlobal's next-generation
cognitive computing engine. The organization is working closely
with ArisGlobal to further leverage advanced technology including
GenAI to revolutionize global pharmacovigilance (PV) processes.
Commenting on this latest prestigious win, Rajendra Hattarki, SVP, Global Head of
Consulting at ArisGlobal, said: "That yet another top-tier
global life sciences brand is actively capitalizing on all that
LifeSphere makes possible in automating key Safety processes, is
further confirmation of the rise in aggressive, important
automation and AI initiatives and priorities, for which LifeSphere
is a core solution - today. We are thrilled to have met this
milestone with such a fantastic organization and anticipate more
success together in the future."
Ann-Marie Orange, CIO and Global
Head of R&D, added: "LifeSphere is a tangible solution for
pharma, enabling the implementation of AI and GenAI solutions right
now. In this latest go-live, our platform is delivering on-demand
access to the very latest advanced automation capabilities,
unprecedented scalability, and effortless regulatory compliance in
each process across this powerful platform. Lifesphere as a SaaS
solution frees up pharma's vital resources previously managing
internal systems and infrastructure. Standardizing on LifeSphere
substantially enhances Safety processes and their efficient
delivery, allowing pharma organizations to focus on their core
business."
About ArisGlobal
ArisGlobal, an innovative life
sciences technology company and creator of LifeSphere®, is
transforming the way today's most successful life sciences
companies develop breakthroughs and bring new products to market.
Headquartered in the United
States, ArisGlobal has regional offices in Europe, India, Japan,
and China. For more updates,
follow ArisGlobal on LinkedIn or visit www.arisglobal.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/top-5-global-biotech-company-goes-live-with-lifesphere-multivigilance-and-reporting--analytics-solution-302183319.html
SOURCE ArisGlobal